Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Downgrades Galapagos to Market Perform

Raymond James Downgrades Galapagos to Market Perform

Raymond James analyst Dane Leone downgrades Galapagos (NASDAQ:GLPG) from Outperform to Market Perform.

byBenzinga Newsdesk

November 7, 2022

1 minute read

Raymond James analyst Dane Leone downgrades Galapagos (NASDAQ:GLPG) from Outperform to Market Perform.

Is Lucid A Buy Following Fund Infusion? Here’s How Much $1,000 Invested In EV Maker Will Be Worth If It Returns To November 2021 Peak

By Shanthi Rexaline

December 21, 8:29 AM

Shares of luxury electric vehicle maker Lucid Group Inc.

LCID

‘GM Has Cut Its Buick Dealership Network In Half Through Buyouts’ – CNBC

By Benzinga Newsdesk

December 19, 5:44 PM

https://www.cnbc.com/2023/12/19/gm-has-cut-its-buick-dealership-network-in-half-through-buyouts.html?__source=sharebar%7Ctwitter&par=sharebarGeneral Motors has roughly halved the size of its Buick dealership network

Analyst Ratings

What 7 Analyst Ratings Have To Say About Silence Therapeutics

By Benzinga Insights

May 17, 9:01 AM

Silence Therapeutics (NASDAQ:SLN) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from…

SLN

Why Minerva Surgical Shares Are Taking Off Wednesday

By Adam Eckert

May 24, 9:40 AM

Minerva Surgical Inc (NASDAQ: UTRS) shares are soaring Wednesday morning after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods.

UTRS

Raymond James Downgrades Galapagos to Market Perform

Related Posts

Is Lucid A Buy Following Fund Infusion? Here’s How Much $1,000 Invested In EV Maker Will Be Worth If It Returns To November 2021 Peak

‘GM Has Cut Its Buick Dealership Network In Half Through Buyouts’ – CNBC

What 7 Analyst Ratings Have To Say About Silence Therapeutics

Why Minerva Surgical Shares Are Taking Off Wednesday